Peripheral Drivers of Heart Failure Progression - The Prospective PEDAL-HF Study
Recruiting
N/A
Interventional Study
Heart Failure - NYHA II - IV
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 1,000 (estimated)
- Sponsor
- University of Leipzig · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
PEDAL-HF is a registry-based randomized prospective multicenter study. The investigators plan to include 1000 patients who were recently admitted with acute decompensated heart failure at five tertiary heart clinics in Germany. For the randomised part, 750 patients will be randomized to care within a heart failure network or usual care. The primary endpoint of the randomized trial is change in NT-…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients admitted to the participating study centres with acute decompensated heart failure (ADHF), defined as clinical signs and/or symptoms of heart failure
* objective structural cardiac abnormalitites according to the ESC criteria.
Exclusion Criteria:
* Age \<18 years
* …
Contacts
Sophie Charlotte Schröder, MD
+49-341-97-12650
sophiecharlotte.schroeder@medizin.uni-leipzig.de
CONTACT